http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
One-Year Open-Label Study of Entacapone in Patients with Advanced Parkinson Disease
안태범,임주혁,이명종,김재우,이원용,전범석 대한신경과학회 2007 Journal of Clinical Neurology Vol.3 No.2
Background and Purpose: A carboxy-O-methyl transferase inhibitor entacapone has been introduced as an adjuvant drug for Parkinson disease (PD) patients. Although clinical trials reported beneficial role of entacapone, a long-term trial over 3 years failed to show significant effect. The goals of this study were to evaluate the clinical benefit and the efficacy of entacapone in an open clinical practice. Methods: After the completion of a double-blind placebo-controlled entacapone study, 149 patients from 4 centers were included. Antiparkinsonian medications were optimized by the judgment of the neurologists in charge. The clinical global impression (CGI) scale was obtained at 6 months and 1 year after the initiation of entacapone treatment. Results: Of the 149 patients, 117 patients chose to try entacapone in an open-label fashion. Sixty-nine (59%) patients completed the 1-year trial. Twenty-nine patients discontinued entacpaone before 6 months, and 19 between 6 months and 1 year during trial. Twelve patients out of 48 patients discontinued entacapone because of its poor efficacy. The CGI scale was 3.9 (±1.5) at the beginning of the trial, 4.3 (±1.1) at 6 month, and 3.8 (±1.3) at 1 year, respectively. The CGI scale of those who discontinued between 6 month and 1 year was 3.4 (±1.7), which was worse, but insignificantly, than that of the continuer. Discussion: The dropout at 1 year of our study was very high at 41%. Even though entacapone is indicated for advanced PD patients with motor fluctuation, the fluctuators commonly have dyskinesia and mental symptoms, which can become more troublesome with entacapone. In the patients with advanced PD, the clinical efficacy and side effects should be carefully considered in a long-term use of entacapone.
과학관에서의 대중 시연을 통한 인간크기 이족보행 휴머노이드 로봇의 평가 연구
안태범,강이석,Ahn, Tae-Beom,Kang, E-Sok 제어로봇시스템학회 2015 제어·로봇·시스템학회 논문지 Vol.21 No.9
Although human-sized bipedal humanoid robots have been developed as the ideal form of human-friendly robots, studies of humanoid robots from the user perspective and of actual interaction between humanoid robots and the public in daily environments are few. This paper presents a long-term public demonstration that encouraged interaction between a humanoid robot and unspecified individuals. We have collected a significant amount of subjective evaluation data from the public by performing a storytelling demonstration that enhanced people's empathy towards the robot. The evaluation model consists of the robot's human friendliness, which involves its impression on humans, interaction with humans, and imitation of human motions and the robot's human appearance which involves gender, age, height, and body type. This study shows that there is no significant difference in human-friendliness between gender groups (male and female), while there is a significant difference between age groups (children and adults). In human appearance, it appears that there is no significant difference between either gender groups or age groups, except for the case of the robot's height.
안태범,이현우,문정기 한국공업화학회 2016 한국공업화학회 연구논문 초록집 Vol.2016 No.0
최근 담수화 공정에서 배출되는 농축수 배출에 따른 환경영향, 농축수량의 저감 및 농축수중 희유금속 추출방법에 대한 연구가 진행중이다. 해수 농축수중 희유금속 회수기술은 대상 물질의 용해도에 따라 적정 농도 이상으로의 농축이 필요하며, 농축공정에서의 에너지 소모가 가장 큼으로 인해 경제적인 생산을 위한 적정 농축도의 결정은 반드시 필요하다. 해수의 농축정도를 평가하는 방법은 다양한 방법이 있으나, 고농도로의 농축시 각 평가방법은 정확성, 재현성, 측정센서의 한계 및 정밀도 부분에서 많은 한계점을 나타냄. 한편 PHREEQC는 USGS에서 개발한 화학평형 모델링 프로그램으로서 batch 또는 연속으로 화학평형 계산이 가능하다. 따라서 본 연구에서는 해수 농축수를 부피비로 단계별 농축함과 동시에 PHREEQC를 이용한 시뮬레이션 결과를 비교하여 수중의 용존되어 있는 이온들의 특성을 파악하고자 한다.